Clinical Trial: Predictive Value of Fetal Modified Myocardial Performance Index and Cerebroplacental-Uterine Ratio for Adverse Perinatal Outcomes in Late Onset Preeclampsia and Diabetes Mellitus

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07811050) titled 'Predictive Value of Fetal Modified Myocardial Performance Index and Cerebroplacental-Uterine Ratio for Adverse Perinatal Outcomes in Late Onset Preeclampsia and Diabetes Mellitus' on Aug. 16.

Brief Summary: High-Risk Pregnancies complicated by gestational diabetes mellitus (GDM) and preeclampsia (PE) represent a significant global health challenge, affecting approximately 15-20% of all pregnancies. These conditions are major contributors to adverse perinatal outcomes, including respiratory distress, neonatal hypoglycemia, and NICU admission. Beyond these, growing evidence suggests that the fetal heart undergoes early structural and...